A cross-national perspective on cost of illness: A comparison of studies from The Netherlands, Australia, Canada, Germany, United Kingdom, and Sweden

European Journal of Health Economics

Volumn 6, Issue 3, 2005, Pages 223-232

  Polder, Johan J ^a   Meerding, Willem Jan ^b   Bonneux, Luc ^b   Van Der Maas, Paul J ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cost of illness; Epidemiology; Health care system; International comparison; Methodology

Indexed keywords

ARTICLE; CANADA; COST OF ILLNESS; DATA ANALYSIS; GERMANY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; SWEDEN; UNITED KINGDOM;

COST OF ILLNESS; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; HEALTH CARE COSTS; HEALTH EXPENDITURES;

EID: 27844438485     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-005-0295-0     Document Type: Article

References (36)

1. Murray C, Lopez A, Jamison D (1994) The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 72:495-509
2. OECD (2004) Towards high-performing health systems - policy studies. Organisation for Economic Co-operation and Development: Paris
3. Polder JJ (2001) Cost of illness in the Netherlands: description, comparison and projection. Thesis, Erasmus University: Rotterdam
4. Reynolds MW, Frame D, Scheye R, Rose ME, George S, Watson JB et al. (2004) A systematic review of the economic burden of chronic angina. Am J Manag Care 10 [Suppl 11]:S347-S357
5. Bazil CW (2004) Comprehensive care of the epilepsy patient-control, comorbidity, and cost. Epilepsia 45 [Suppl 6]:3-12
6. Polder JJ, Takken J, Meerding WJ, Kommer GJ, Stokx LJ (2002) Kosten van ziekten in Nederland: de zorgeuro ontrafeld. RIVM: Bilthoven
7. Rice DP (1966) Estimating the cost of illness. Health economic series no. 6, DHEW publ no (PHS) 947-6. Department of Health, Education and Welfare: Rockville
8. Cooper B, Rice D (1976) The economic cost of illness revisited. Soc Secur Bull 39:3-20:48
9. Rice DP, Hodgson TA, Kopstein AN (1985) The economic costs of illness: a replication and update. Health Care Financ Rev 7:61-80
10. Lindgren B (1981) Cost of illness in Sweden, 1964-1975. Institutet for Hälsökonomi: Lund
11. Koopmanschap MA, Roijen L van, Bonneux L (1991) Kosten van ziekten in Nederland. Erasmus University: Rotterdam
12. Wigle DT, Mao Y, Wong T, Lane R (1991) Economic burden of illness in Canada in 1986. Chronic Dis Can 12 [Suppl]
13. Henke KD, Behrens CS (1986) The economic cost of illness in the Federal Republic of Germany in the year 1980. Health Policy 6:119-143
14. Mathers C, Penm R, Carter R, Stevenson C (1998) Health system costs of diseases and injury in Australia 1993-94. An analysis of costs, services use and mortality for major disease and injury groups. Australian Institute of Health and Welfare: Canberra
15. Moore R, Mao Y, Zhang J, Clarke K (1997) Economic burden of illness in Canada, 1993. Minister of Public Works and Government Services: Toronto
16. Jacobson L, Lindgren B (1996) Vad kostar sjukdomarna? Sjukvårdskostnader och produktionsbortfall fördelat på sjukdomsgrupper 1980 och 1991. Socialstyrelsen: Stockholm
17. NHS Executive (1996) Burdens of disease - a discussion document. Office for National Statistics: Wetherby
18. Schneider M, Martin K, Henke KD, Behrens C (1999) Kosten nach Krankheitsarten. Statistisches Bundesamt: Wiesbaden
19. Polder JJ, Meerding WJ, Koopmanschap MA, Bonneux L, Maas PJ van der (1997) Kosten van ziekten in Nederland 1994. Erasmus University: Rotterdam
20. OECD (1998) Health data 1998. Organisation for Economic Co-operation and Development, CREDES: Paris
21. WHO (1977) International statistical classification of diseases, injuries and causes of death (ICD-9). World Health Organisation: Geneva
22. Mathers C, Penm R, Sanson-Fisher R, Carter R, Campbell E (1998) Health system costs of cancer in Australia 1993-94. Australian Institute of Health and Welfare: Canberra
23. Eurostat (2000) Key data on health 2000 - data 1985-1995. European Commission: Luxembourg
24. Page Y (2001) A statistical model to compare road mortality in OECD countries. Accid Anal Prev 33:371-385
25. Mosseveld CJPM van, Son P van (1998) International comparison of health care data - methodology development and application. Kluwer: Voorburg
26. OECD (2000) A system of health accounts. Organisation for Economic Cooperation and Development: Paris
27. WHO Collaborating Centre for Drug Statistics Methodology (1994) Anatomical Therapeutical Chemical (ATC) classification index, including defined daily doses (DDDs) for plain substances 1995. World Health Organization: Oslo
28. Looper MD, Bhatia K (1998) International health - how Australia compares. Australian Institute on Health and Welfare: Canberra
29. Drummond M, Jonsson B, Rutten F (1997) The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy 40:199-215
30. McDermott RA, Tulip F, Schmidt B (2004) Diabetes care in remote northern Australian Indigenous communities. Med J Aust 180:512-516
31. Arah OA, Klazinga NS, Delnoij DM, ten Asbroek AH, Custers T (2003) Conceptual frameworks for health systems performance: a quest for effectiveness, quality, and improvement. Int J Qual Health Care 15:377-398
32. Koopmanschap MA (1998) Cost-of-illness studies - useful for health policy? Pharmacoeconomics 14:143-148
33. Bloom BS, Bruno DJ, Maman DY, Jayadevappa R (2001) Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 19:207-213
34. Ament A, Evers S (1993) Cost of illness studies in health care: a comparison of two cases. Health Policy 26:29-42
35. Norlund A, Apelqvist J, Bitzen PO, Nyberg P, Schersten B (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250:57-65
36. Lee DW, Meyer JW, Clouse J (2001) Implications of controlling for co-morbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. Value Health 4:329-334